NASDAQ:ELDN

Eledon Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy ELDN

*Your capital is at risk

$3.38

-0.0300 (-0.88%)

At Close: Jul 31, 2026

Eledon Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 48.88M and sold 0 ELDN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	48.88M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 09, 2024 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	3 173 135 Value: $3K
May 09, 2024 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	821 121 Value: $1.95M
May 09, 2024 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	2 526 238 Value: $3K
May 09, 2024 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	232 068 Value: $232
May 09, 2024 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	75 431 Value: $178.8K
May 09, 2024 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	75 431 Value: $178.8K
May 09, 2024 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	232 068 Value: $232
May 09, 2024 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	2 526 238 Value: $3K
May 09, 2024 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	821 121 Value: $1.95M
May 09, 2024 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	3 173 135 Value: $3K
May 09, 2024 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	1 031 385 Value: $2.44M
Oct 02, 2023 Buy	Stock Option (Right to Buy) A-Award	Robinson James A. Jr. Director	Director	150 437 Value: $233.2K
Oct 02, 2023 Buy	Stock Option (Right to Buy) A-Award	Kirk Allan Director	Director	150 437 Value: $233.2K
Oct 02, 2023 Buy	Stock Option (Right to Buy) A-Award	Kirk Allan Director	Director	150 437 Value: $233.2K
Oct 02, 2023 Buy	Stock Option (Right to Buy) A-Award	Robinson James A. Jr. Director	Director	150 437 Value: $233.2K
Oct 02, 2023 Buy	Common Stock J-Other	Kirk Allan	Director	0 Value: $0
Oct 02, 2023 Buy	Common Stock J-Other	Kirk Allan	Director	0 Value: $0
Oct 01, 2023 Buy	Common Stock J-Other	Robinson James A. Jr.	Director	0 Value: $0
Oct 01, 2023 Buy	Common Stock J-Other	Robinson James A. Jr.	Director	0 Value: $0
May 05, 2023 Buy	Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	3 084 090 Value: $9.25M
May 05, 2023 Buy	Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	2 446 209 Value: $7.34M
May 05, 2023 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	1 055 445 Value: $2.44M
May 05, 2023 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	2 028 645 Value: $2K
May 05, 2023 Buy	Common Stock, $0.001 par value P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	837 146 Value: $1.93M
May 05, 2023 Buy	Pre-funded Warrants to Purchase Common Stock P-Purchase	Bvf Partners L P/il 10 Percent Owner	10% Owner	1 609 063 Value: $2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ELEDON PHARMACEUTICALS, INC.

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical tri...

Read Full Profile Here